Cambridge Investment Research Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.1M Sell
299,079
-3,344
-1% -$305K 0.06% 323
2026
Q1
$31.1M Sell
302,423
-28,781
-9% -$3.25M 0.08% 249
2025
Q4
$41.5M Buy
331,204
+39,573
+14% +$5.04M 0.11% 177
2025
Q3
$39.1M Buy
291,631
+11,308
+4% +$1.48M 0.11% 172
2025
Q2
$38.1M Sell
280,323
-395
-0.1% -$52.1K 0.12% 167
2025
Q1
$37.2M Sell
280,718
-31,548
-10% -$4.02M 0.13% 152
2024
Q4
$35.3M Sell
312,266
-2,937
-0.9% -$339K 0.12% 161
2024
Q3
$35.9M Buy
315,203
+22,849
+8% +$2.51M 0.12% 164
2024
Q2
$30.4M Sell
292,354
-6,888
-2% -$730K 0.11% 169
2024
Q1
$34M Buy
299,242
+23,614
+9% +$2.71M 0.13% 146
2023
Q4
$30.3M Buy
275,628
+14,860
+6% +$1.48M 0.13% 154
2023
Q3
$25.3M Sell
260,768
-21,737
-8% -$2.28M 0.12% 171
2023
Q2
$30.8M Buy
282,505
+26,202
+10% +$2.79M 0.14% 143
2023
Q1
$26M Sell
256,303
-14,848
-5% -$1.57M 0.13% 165
2022
Q4
$29.8M Buy
271,151
+5,522
+2% +$572K 0.15% 130
2022
Q3
$25.7M Buy
265,629
+414
+0.2% +$44.1K 0.14% 141
2022
Q2
$28.8M Buy
265,215
+1,166
+0.4% +$132K 0.16% 134
2022
Q1
$31.3M Sell
264,049
-10,161
-4% -$1.26M 0.14% 139
2021
Q4
$38.6M Buy
274,210
+4,346
+2% +$556K 0.17% 111
2021
Q3
$31.9M Buy
269,864
+3,571
+1% +$439K 0.16% 126
2021
Q2
$30.9M Buy
266,293
+711
+0.3% +$82.9K 0.15% 136
2021
Q1
$31.8M Sell
265,582
-542
-0.2% -$64.2K 0.17% 116
2020
Q4
$29.1M Buy
266,124
+1,431
+0.5% +$156K 0.17% 117
2020
Q3
$28.8M Buy
264,693
+15,576
+6% +$1.58M 0.19% 108
2020
Q2
$22.8M Buy
249,117
+7,259
+3% +$656K 0.17% 128
2020
Q1
$19.1M Buy
241,858
+10,244
+4% +$855K 0.18% 120
2019
Q4
$20.1M Buy
231,614
+21,141
+10% +$1.77M 0.16% 135
2019
Q3
$17.6M Buy
210,473
+3,254
+2% +$276K 0.15% 139
2019
Q2
$17.4M Sell
207,219
-8,348
-4% -$657K 0.16% 137
2019
Q1
$17.2M Buy
215,567
+9,890
+5% +$736K 0.16% 130
2018
Q4
$14.9M Sell
205,677
-4,601
-2% -$323K 0.16% 130
2018
Q3
$15.4M Buy
210,278
+5,028
+2% +$330K 0.15% 148
2018
Q2
$12.5M Buy
205,250
+3,095
+2% +$188K 0.13% 156
2018
Q1
$12.1M Buy
202,155
+3,327
+2% +$200K 0.14% 150
2017
Q4
$11.3M Buy
198,828
+18,313
+10% +$1.01M 0.13% 156
2017
Q3
$9.63M Buy
180,515
+3,388
+2% +$170K 0.13% 152
2017
Q2
$8.61M Buy
+177,127
New +$8.02M 0.13% 150
2016
Q4
Sell
-158,933
Closed -$6.72M 1668
2016
Q3
$6.72M Buy
+158,933
New +$6.81M 0.12% 146
2016
Q2
Sell
-121,682
Closed -$5.09M 1560
2016
Q1
$5.09M Buy
121,682
+1,023
+0.8% +$40.5K 0.12% 161
2015
Q4
$5.42M Buy
+120,659
New +$5.33M 0.13% 147
2015
Q3
Sell
-131,161
Closed -$6.44M 1438
2015
Q2
$6.44M Sell
131,161
-3,628
-3% -$174K 0.18% 118
2015
Q1
$6.25M Sell
134,789
-11,582
-8% -$532K 0.18% 118
2014
Q4
$6.59M Buy
146,371
+4,481
+3% +$195K 0.2% 106
2014
Q3
$5.9M Buy
141,890
+10,647
+8% +$450K 0.17% 124
2014
Q2
$5.37M Buy
131,243
+5,359
+4% +$210K 0.19% 112
2014
Q1
$4.85M Buy
125,884
+4,822
+4% +$186K 0.18% 114
2013
Q4
$4.64M Buy
121,062
+1,143
+1% +$42.1K 0.19% 114
2013
Q3
$3.98M Buy
119,919
+5,138
+4% +$180K 0.17% 123
2013
Q2
$4M Buy
+114,781
New +$4.21M 0.2% 106

Other funds holding ABT

Cambridge Investment Research Advisors's ABT Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Abbott (ABT) stake by 1.1% in Q2 2026, selling an estimated $305K and leaving 299,079 shares worth $27.1M. The position accounts for 0.06% of the portfolio, ranked #323.

Cambridge Investment Research Advisors first reported a position in ABT in Q2 2013 and has held it in 49 quarters since. The position peaked at $41.5M in Q4 2025. 2,950 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Cambridge Investment Research Advisors held 299,079 shares of Abbott worth $27.1M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 3,344 Abbott shares in Q2 2026, an estimated $305K.
  • Abbott made up 0.06% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #323 holding.
  • Cambridge Investment Research Advisors first reported a position in Abbott in Q2 2013 and has held it in 49 quarters since.
  • Cambridge Investment Research Advisors's Abbott position peaked at $41.5M in Q4 2025.
  • 2,950 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.